These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25780066)

  • 41. Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers.
    Celik A; Tiryaki S; Musayev A; Kismali E; Levent E; Ergun O
    J Drugs Dermatol; 2012 Jul; 11(7):808-11. PubMed ID: 22777220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac screening in infants with infantile hemangiomas before propranolol treatment.
    Blei F; McElhinney DB; Guarini A; Presti S
    Pediatr Dermatol; 2014; 31(4):465-70. PubMed ID: 24889812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preliminary experiences in treating infantile hemangioma with propranolol.
    Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
    Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hemangiomas in childhood].
    Schöni MH; Kernland Lang K
    Praxis (Bern 1994); 2011 May; 100(10):575-82, quiz 583-4. PubMed ID: 21563093
    [No Abstract]   [Full Text] [Related]  

  • 45. Beta blocker treatment of infantile conjunctival hemangiomas--observations from 2 cases.
    Chang TC; Estes R
    J AAPOS; 2014 Feb; 18(1):80-2. PubMed ID: 24568991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy.
    Yeh I; Bruckner AL; Sanchez R; Jeng MR; Newell BD; Frieden IJ
    Pediatr Dermatol; 2011; 28(3):267-75. PubMed ID: 21517953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
    Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
    Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Infantile hemangiomas: the revolution of beta-blockers].
    Leaute-Labreze C
    Rev Prat; 2014 Dec; 64(10):1421-8. PubMed ID: 25665327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Propranolol in the treatment of problematic infantile hemangiomas].
    Lu J; Qin G; Huang J; Li S; Zhao J; Xiang Y; Chen J; Zuo C; Yang S; Tna L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1102-5. PubMed ID: 22169728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
    Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
    Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploration of the optimal time to discontinue propranolol treatment in infantile hemangiomas: A prospective study.
    Wang L; Wang W; Zhou Z; Li J; Li Z; Lv R; Xu G; Bi J; Huo R
    J Am Acad Dermatol; 2024 Apr; 90(4):783-789. PubMed ID: 38159645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
    Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
    Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Propranolol use for infantile hemangiomas: American Society of Pediatric Otolaryngology Vascular Anomalies Task Force practice patterns.
    Parikh SR; Darrow DH; Grimmer JF; Manning SC; Richter GT; Perkins JA
    JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):153-6. PubMed ID: 23429945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful discontinuation of propranolol for infantile hemangiomas of the head and neck at 12 months of age.
    Hong P; Tammareddi N; Walvekar R; Chiu ES; Poole JC; Kluka EA; Simon LM
    Int J Pediatr Otorhinolaryngol; 2013 Jul; 77(7):1194-7. PubMed ID: 23706952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful management of airway hemangioma with propranolol.
    Mendiratta V; Varghese B; Chander R; Parakh A; Solanki RS
    Int J Dermatol; 2013 Jun; 52(6):750-2. PubMed ID: 23679882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
    Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
    Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Infantile Hemangiomas: Pathogenesis and Review of Propranolol Use.
    Laken PA
    Adv Neonatal Care; 2016 Apr; 16(2):135-42. PubMed ID: 26945282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of infantile hemangiomas with beta-blockers: a review.
    Shah S; Frieden IJ
    Skin Therapy Lett; 2013; 18(6):5-7. PubMed ID: 24305730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Propranolol for Treatment of Genital Infantile Hemangioma.
    Tran C; Tamburro J; Rhee A; Golden A
    J Urol; 2016 Mar; 195(3):731-7. PubMed ID: 26400030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diffuse neonatal hemangiomatosis: a case report.
    Martínez-Escanamé M; Castillo-Martínez C; Torres-Álvarez B; González FJ; Oros-Valle C; Moncada B
    Int J Dermatol; 2012 Oct; 51(10):1228-30. PubMed ID: 21470219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.